SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027992
Filing Date
2018-11-07
Accepted
2018-11-07 16:02:48
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q derm-10q_20180930.htm 10-Q 2104821
2 EX-31.1 derm-ex311_6.htm EX-31.1 16931
3 EX-31.2 derm-ex312_7.htm EX-31.2 17593
4 EX-32.1 derm-ex321_9.htm EX-32.1 5774
5 EX-32.2 derm-ex322_8.htm EX-32.2 6402
  Complete submission text file 0001564590-18-027992.txt   6118082

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT derm-20180930.xml EX-101.INS 1185033
7 XBRL TAXONOMY EXTENSION SCHEMA derm-20180930.xsd EX-101.SCH 42351
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE derm-20180930_cal.xml EX-101.CAL 46628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE derm-20180930_def.xml EX-101.DEF 158006
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE derm-20180930_lab.xml EX-101.LAB 317090
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE derm-20180930_pre.xml EX-101.PRE 256831
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36668 | Film No.: 181166212
SIC: 2834 Pharmaceutical Preparations